ChECMating cellular senescence by modulating the surrounding matrisome
This project aims to investigate how extracellular matrix composition influences the accumulation of senescent cells, potentially revolutionizing approaches to aging and tissue fibrosis.
Projectdetails
Introduction
The increasing elderly population poses a dual challenge to the viability of both global health and our current welfare systems. One of the pivotal aspects of aging involves the accumulation of damaged cells, known as senescent cells, in organs.
Impact of Senescent Cells
While these cells play a role in coordinating tissue repair whenever damage occurs, their aberrant accumulation disturbs normal tissue function, resulting in an unbearable burden that ultimately leads to aging. Understanding how these cells accumulate within the organism, a yet unresolved question, would offer invaluable insights into the aging process.
Role of Integrins
We have recently reported that damaged cells rely on Integrins, a family of membrane proteins, to implement senescence over cell death, leading to their accumulation within injured tissues. Remarkably, Integrins are known as the major cellular receptors binding to the surrounding extracellular matrix (ECM).
Research Objectives
Considering these precedents, we aim to take a step further and investigate whether the composition and status of the ECM can influence the buildup of senescent cells by impacting the choice between senescence and cell death upon injury, a possibility not explored before.
Specific Aims
Here, we aim to assess whether certain ECM proteins might act as pro-senescence factors by desensitizing damaged cells to death, favoring survival and aberrant senescence instead.
Methodology
We will thoroughly characterize multiple cell culture and mouse models of senescence implementation following damage, aiming to unveil the mechanisms controlling this phenomenon.
Expected Outcomes
Leveraging these findings, we will modulate the occurrence of cell senescence through ECM reengineering in mice, seeking to establish a revolutionary approach to address aging and tissue fibrosis.
Conclusion
In sum, by uncovering unsuspected links between the ECM status and cell senescence implementation, ChECMate senescence would signify a paradigm change that would enable an unprecedented strategy in targeting cellular senescence in detrimental scenarios.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.496.867 |
Totale projectbegroting | € 1.496.867 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Harnessing senescence to improve cell-based therapies against cancerThis project aims to enhance cancer therapy by combining senescence induction with CAR T and NK cell strategies to improve treatment outcomes and understand immune interactions in tumors. | ERC Starting... | € 1.499.975 | 2025 | Details |
CHARTING THE TOKEN OF TIME: YAP/TAZ TRANSCRIPTIONAL REGULATORS AT THE ROOTS OF AGINGThis project aims to unravel the mechanisms of aging by investigating YAP/TAZ signaling in stromal cells and its role in cellular communication and senescence, potentially revealing new anti-aging strategies. | ERC Advanced... | € 2.811.871 | 2024 | Details |
The extracellular matrix as a mediator of cell-cell communication in cardiovascular inflammationThe project aims to explore the extracellular matrix proteome in atherosclerosis and myocardial infarction to identify novel therapeutic targets for individualized treatment strategies. | ERC Starting... | € 1.495.750 | 2023 | Details |
The Interplay of Aging, Immune Signaling and Stem Cell FunctionThis project aims to investigate how immune environment changes contribute to muscle stem cell dysfunction and regenerative decline in aging, with the goal of improving stem cell therapies. | ERC Consolid... | € 1.998.843 | 2024 | Details |
Letting up senescence and inflammaging through T cellsLetTBe aims to investigate T cell metabolism and its role in aging to develop strategies that prevent immunosenescence and promote healthy aging. | ERC Consolid... | € 1.999.944 | 2023 | Details |
Harnessing senescence to improve cell-based therapies against cancer
This project aims to enhance cancer therapy by combining senescence induction with CAR T and NK cell strategies to improve treatment outcomes and understand immune interactions in tumors.
CHARTING THE TOKEN OF TIME: YAP/TAZ TRANSCRIPTIONAL REGULATORS AT THE ROOTS OF AGING
This project aims to unravel the mechanisms of aging by investigating YAP/TAZ signaling in stromal cells and its role in cellular communication and senescence, potentially revealing new anti-aging strategies.
The extracellular matrix as a mediator of cell-cell communication in cardiovascular inflammation
The project aims to explore the extracellular matrix proteome in atherosclerosis and myocardial infarction to identify novel therapeutic targets for individualized treatment strategies.
The Interplay of Aging, Immune Signaling and Stem Cell Function
This project aims to investigate how immune environment changes contribute to muscle stem cell dysfunction and regenerative decline in aging, with the goal of improving stem cell therapies.
Letting up senescence and inflammaging through T cells
LetTBe aims to investigate T cell metabolism and its role in aging to develop strategies that prevent immunosenescence and promote healthy aging.